Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Regan

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2022
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19)Julie Boucau, Rockib Uddin, Caitlin Marino, et al.
The Journal of Infectious Diseases|May 8, 2024
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2Manish C Choudhary, Rinki Deo, Teresa H Evering, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 studyEvelyn Kung, Rinki Deo, Manish C Choudhary, et al.
The New England Journal of Medicine|June 29, 2022
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) InfectionJulie Boucau, Caitlin Marino, James Regan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Duration of viable virus shedding in SARS-CoV-2 omicron variant infectionJulie Boucau, Caitlin Marino, James Regan, et al.
Pathogens & Immunity|May 20, 2026
Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19Evelyn Kung, Rinki Deo, Manish C Choudhary, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infectionJulie Boucau, Kara W Chew, Manish Choudhary, et al.
Cell Reports. Medicine|July 6, 2022
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infectionJulie Boucau, Kara W Chew, Manish C Choudhary, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2021
Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After VaccinationCrystal M North, Amy Barczak, Robert H Goldstein, et al.
Nature Communications|October 31, 2020
SARS-CoV-2 viral load is associated with increased disease severity and mortalityJesse Fajnzylber, James Regan, Kendyll Coxen, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2022
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19)Julie Boucau, Rockib Uddin, Caitlin Marino, et al.
The Journal of Infectious Diseases|May 8, 2024
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2Manish C Choudhary, Rinki Deo, Teresa H Evering, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 studyEvelyn Kung, Rinki Deo, Manish C Choudhary, et al.
The New England Journal of Medicine|June 29, 2022
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) InfectionJulie Boucau, Caitlin Marino, James Regan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Duration of viable virus shedding in SARS-CoV-2 omicron variant infectionJulie Boucau, Caitlin Marino, James Regan, et al.
Pathogens & Immunity|May 20, 2026
Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19Evelyn Kung, Rinki Deo, Manish C Choudhary, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infectionJulie Boucau, Kara W Chew, Manish Choudhary, et al.
Cell Reports. Medicine|July 6, 2022
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infectionJulie Boucau, Kara W Chew, Manish C Choudhary, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2021
Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After VaccinationCrystal M North, Amy Barczak, Robert H Goldstein, et al.
Nature Communications|October 31, 2020
SARS-CoV-2 viral load is associated with increased disease severity and mortalityJesse Fajnzylber, James Regan, Kendyll Coxen, et al.
Pageof 6